Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
AFN-12520000
and promoted radiation sensitization in DDX3-overexpressing cells
topiramate was approved by the United States Food and Drug Administration (FDA) in combination with phentermine for weight loss
with significant suppression of tumor growth upon daily oral dosing at 10 and 30 mg/kg (%T/C = 68% and 20%
Chemical Name: 8-(2-phenylethyl)-1-oxa-3
Thalidomide-Propargyne-PEG2-COOH lafenamide hemifumarate AFN-12520000Thalidomide Propargyne PEG2 COOH is a synthesized E3 ligase ligand linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. Product information Molecular Weight: 428. 39 Formula: C21H20N2O8 Chemical Name: 3 [2 ({3 [2 (2, 6 dioxopiperidin 3 yl) 1, 3 dioxo 2, 3 dihydro 1H isoindol 5 yl]prop 2 yn 1 yl}oxy)ethoxy]propanoic acid Smiles: OC(=O)CCOCCOCC#CC1=CC2=C(C=C1)C(=O)N(C1CCC(=O)NC1=O)C2=O
US$ 909.50
US$ 1070.00
US$ 842.62
US$ 642.00
US$ 802.50
US$ 749.00
US$ 695.50
US$ 1284.00